Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: J Allergy Clin Immunol. 2016 Mar 23;138(2):544–550.e4. doi: 10.1016/j.jaci.2016.01.018

Table 1. Humoral Immunophenotype for proband, sibling and father.

Immunoglobulin totals show consistent adolescent onset of CVID in the proband (P), brother (B), and father (F). Values for the father (F) prior to IVIG therapy were not available. Bolded values are abnormal, normal ranges are in parentheses. Values with an asterisk (*) denote levels while on immunoglobulin replacement.

Patient F F B B B B P P P P
Age at analysis 46 65 14 15 17 25 17 18 19 23
IgG (mg/dl) 559* (717–1411) 1550* (717–1411) 815 (717–1411) 712 (600–1600) 391 (600–1600) 2030* (717–1411) 926 (700–1600) 687 (700–1600) 620 (700–1600) 1190* (635–1775)
IgG1 738 (315–855) 582 (155–1020) 313 (155–1020) 767 (490–1140)
IgG2 17 (64–495) 17 (44–495) <12 (44–495) 42 (150–640)
IgG3 42 (23–196) 23 (8–209) 19 (8–209) 15 (11–85)
IgA (mg/dl) <13 (78391) <7 (78–391) <7 (78–391) <5.9 (70–315) <5.9 (70–315) <7 (717–1411) <7 (70–400) <7 (70–400) <6 (70–486)
IgM (mg/dl) 27 (53–334) 27 (53–334) 35 (53–334) 22.4 (40–250) 6.8 (40–250) 12 (53–334) <10 (40–230) <10 (40–230) <4 (71–237)